{"id":"https://genegraph.clinicalgenome.org/r/e7f7f34e-9771-4e26-acb3-9392fca74988v1.0","type":"EvidenceStrengthAssertion","dc:description":"*CERS1* was first reported in relation to autosomal recessive (AR) progressive myoclonus epilepsy in 2014 (Vanni et al., PMID: 24782409). Phenotypic features in individuals with biallelic *CERS1* variants include action myoclonus, myoclonic jerks, seizures (tonic clonic and febrile), truncal and appendicular ataxia, dysarthria, nystagmus, and progressive cognitive deterioration with onset in early to late childhood (Vanni et al., PMID: 24782409; Ferlazzo et al., PMID: 27618929; Goderio Junior et al., PMID: 30800706; Courage et al., PMID: 33798445). Cerebellar and brainstem atrophy have been reported on brain MRI. Seven affected individuals from 3 families with unique homozygous variants are included in this curation (Vanni et al., PMID: 24782409; Ferlazzo et al., PMID: 27618929; Goderio Junior et al., PMID: 30800706; Courage et al., PMID: 33798445). The mechanism of pathogenicity appears to be loss of function of CerS1 activity responsible for the synthesis of C18 ceramides (Vanni et al., PMID: 24782409). This gene-disease relationship is also supported by mouse models (Zhao et al., PMID: 21625621; Ginkel et al., PMID: 23074226). A frameshift variant expected to result in nonsense mediated decay arose spontaneously in “flincher” mice at Jackson Laboratory and, although homozygous mice do not develop spontaneous seizures, they developed cerebellar ataxia and cerebellar degeneration. A second CerS1 deficient mouse model homozygous for a deletion of the catalytic domain demonstrates decreased synthesis of gangliosides, cerebellar degeneration, and behavior and locomotion defects. The genetic evidence score is 4.2 points, and the experimental evidence score is 2 points for a total of 6.2 points. This score falls between the limited and moderate classification. The GCEP elected to classify this gene as moderate as the collective evidence supports a valid gene disease relationship, but this condition appears to be very rare. In summary, there is moderate evidence supporting the relationship between *CERS1* and autosomal recessive progressive myoclonus epilepsy. This classification was approved by the ClinGen Epilepsy GCEP on the meeting date July 16, 2024 (SOP Version 10).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/e7f7f34e-9771-4e26-acb3-9392fca74988","GCISnapshot":"https://genegraph.clinicalgenome.org/r/b06288c1-72ae-4ed0-8a27-f886547a8808","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/b06288c1-72ae-4ed0-8a27-f886547a8808_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2024-07-16T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/b06288c1-72ae-4ed0-8a27-f886547a8808_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2024-07-30T21:19:49.433Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b06288c1-72ae-4ed0-8a27-f886547a8808_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec5ba13b-d324-4ec4-80fc-99bbb30fe46e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6a58067-eb48-4afc-ae71-25b18a7d1b2c","type":"EvidenceLine","dc:description":"Downgraded due to consanguinity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6a58067-eb48-4afc-ae71-25b18a7d1b2c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33798445","allele":{"id":"https://genegraph.clinicalgenome.org/r/19370df6-17ba-4135-8b6f-c5c561e53c4a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001492.6(GDF1):c.-1113G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA404868308"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ec5ba13b-d324-4ec4-80fc-99bbb30fe46e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33798445","rdfs:label":"Courage PME7","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/19370df6-17ba-4135-8b6f-c5c561e53c4a"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Action myoclonus, ataxia, seizures, cognitive impairment.","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b6a58067-eb48-4afc-ae71-25b18a7d1b2c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b06288c1-72ae-4ed0-8a27-f886547a8808_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73c2b45c-1ef0-4437-b842-fa621a639c8c_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24782409","rdfs:label":"Vanni Family 1","estimatedLodScore":2.06,"family":{"id":"https://genegraph.clinicalgenome.org/r/73c2b45c-1ef0-4437-b842-fa621a639c8c","type":"Family","rdfs:label":"Vanni Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/1ab7718b-42bd-4fa9-ad0b-5c8383729471","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24782409","rdfs:label":"Vanni III:2","allele":{"id":"https://genegraph.clinicalgenome.org/r/c8305fea-0192-4f7d-8ca6-75d1e286c74d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001492.6(GDF1):c.-774C>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA185990"}},"firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"Seizures, action myoclonus, progressive cognitive deterioration, cerebellar and brainstem atrophy","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ef9b429b-c97c-4566-95ef-1b81bdffd08c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24782409","allele":{"id":"https://genegraph.clinicalgenome.org/r/c8305fea-0192-4f7d-8ca6-75d1e286c74d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/1ab7718b-42bd-4fa9-ad0b-5c8383729471"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/84c56d32-0bd9-46ed-b741-2a546e6c9d68_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33798445","rdfs:label":"Courage Family 1","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/84c56d32-0bd9-46ed-b741-2a546e6c9d68","type":"Family","rdfs:label":"Courage Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/ec5ba13b-d324-4ec4-80fc-99bbb30fe46e"}},"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ec5ba13b-d324-4ec4-80fc-99bbb30fe46e"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/19d46f51-f177-4b34-8652-53cd483c0057_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7491628b-9c31-4c34-87db-f3d8f7fd27fc","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7491628b-9c31-4c34-87db-f3d8f7fd27fc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30800706","allele":{"id":"https://genegraph.clinicalgenome.org/r/d53d4f22-06da-4997-9a1f-5f31686c938f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001492.6(GDF1):c.-560C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA404865665"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/19d46f51-f177-4b34-8652-53cd483c0057","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30800706","rdfs:label":"Godeiro 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d53d4f22-06da-4997-9a1f-5f31686c938f"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Appendicular ataxia, developmental delay, seizures, myoclonic jerks, dysarthria, horizontal-torsional nystagmus, brainstem atrophy on MRI","previousTesting":true,"previousTestingDescription":"Friedreich's ataxia, spinocerebellar ataxias types 1, 2, 3, 6, 7, 12, 17 and dentatorubropallidoluysian atrophy molecular analysis.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7491628b-9c31-4c34-87db-f3d8f7fd27fc_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/1ab7718b-42bd-4fa9-ad0b-5c8383729471_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef9b429b-c97c-4566-95ef-1b81bdffd08c","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef9b429b-c97c-4566-95ef-1b81bdffd08c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Authors transfected WT H183-tagged and mutant Q183-CerS1 V5-tagged vectors into HeLa cells.  Q183-CerS1 was expressed similarly to wild type and was properly localized to ER compartment.  HeLa cells transiently transfected with WT and mutant CERS1 were subjected to lipid analysis by mass spectrometry. Overexpression of WT-CerS1 increased cellular levels of C18:0 and C18:1 dihydroceramides and ceramides 10-fold or more compared to untransfected control cells, while Q183-Cers1 did not result in any significant increase in C18-ceramide cellular levels, suggesting that this mutation severely impairs CerS1 activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ef9b429b-c97c-4566-95ef-1b81bdffd08c_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/1ab7718b-42bd-4fa9-ad0b-5c8383729471"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":4.2},{"id":"https://genegraph.clinicalgenome.org/r/b06288c1-72ae-4ed0-8a27-f886547a8808_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b06288c1-72ae-4ed0-8a27-f886547a8808_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fea8c8fe-25ba-47a7-8fc1-5a454b581f09","type":"EvidenceLine","dc:description":"Both mouse models were combined to give a sum of 2 points for experimental evidence.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a026062-4539-4d0e-ac67-f54de8c7f6a6","type":"Finding","dc:description":"Although spontaneous seizures are not reported in the mouse model, the mouse model demonstrates motor impairment, structural brain abnormalities, and biochemical findings consistent with the human phenotype. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23074226","rdfs:label":"Ginkel Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b5eef4e1-8b78-4935-a5be-293a4db67947","type":"EvidenceLine","dc:description":"Both mouse models were combined to give a sum of 2 points for experimental evidence.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42909d8f-b9bb-4fee-b0f7-ec42dbb001a7","type":"Finding","dc:description":"Although the mouse model does not present with spontaneous seizures, the mouse model demonstrates ataxia and cerebellar degeneration similar to the presentation in humans.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21625621","rdfs:label":"Zhao Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Moderate","sequence":8755,"specifiedBy":"GeneValidityCriteria10","strengthScore":6.2,"subject":{"id":"https://genegraph.clinicalgenome.org/r/FUE4GKBSDz4","type":"GeneValidityProposition","disease":"obo:MONDO_0020074","gene":"hgnc:14253","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_b06288c1-72ae-4ed0-8a27-f886547a8808-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}